to determine the effect of ketoconazole , a nonestrogenic antifungal agent , in patients with metastatic prostatic cancer 13 patients with symptomatic stage d2 prostatic cancer were administered 400 mg. ketoconazole orally every 8 hours .
C0003308
antifungal agent
C0022625
ketoconazole